D'Altilio M, Peal A, Alvey M, et al. Therapeutic efficacy and safety of undenatured type II collagen singly or in combination with glucosamine and chondroitin in arthritic dogs. Toxicology Mechanisms and Methods. 2007. PubMed. https://pubmed.ncbi.nlm.nih.gov/20020968/
Evaluation of the Effects of Undenatured Type II Collagen (UC-II) as Compared to Robenacoxib on the Mobility Impairment Induced by Osteoarthritis in Dogs. PMC. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6789547/
Barbeau-Grégoire M, Otis C, Cournoyer A, et al. A 2022 Systematic Review and Meta-Analysis of Enriched Therapeutic Diets and Nutraceuticals in Canine and Feline Osteoarthritis. International Journal of Molecular Sciences. 2022. PMC. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9499673/
Merck Veterinary Manual. Osteoarthritis in Dogs and Cats. https://www.merckvetmanual.com/musculoskeletal-system/osteoarthritis-in-dogs-and-cats/osteoarthritis-in-dogs-and-cats
Cabezas MÁ, Benito J, Ortega Á, Garcia-Pedraza E. Long-term supplementation with an undenatured type-II collagen (UC-II) formulation in dogs with degenerative joint disease: Exploratory study. Open Veterinary Journal. 2022. PMC. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8956235/
Gencoglu H, Orhan C, Sahin E, Sahin K. Undenatured Type II Collagen (UC-II) in Joint Health and Disease: A Review on the Current Knowledge of Companion Animals. Animals (Basel). 2020;10(4):697. PMC. https://pmc.ncbi.nlm.nih.gov/articles/PMC7222752/